Biocon shares surge 5% as Malaysia arm gets compliance certificate
Biocon shares surge over 5% after the company said its Malaysian arm has received a compliance certificate from the Health Products Regulatory Authority of Ireland
New Delhi: Shares of biopharmaceutical firm Biocon on Friday surged over 5% after the company said its Malaysian arm Biocon Sdn Bhd has received EU GMP compliance certificate from the Health Products Regulatory Authority of Ireland for its insulin manufacturing facility.
After making a positive opening, shares of the company further jumped 5.32% to Rs353 on BSE. At NSE, shares of the company gained 5.45% to Rs353. “Biocon’s subsidiary in Malaysia, Biocon Sdn Bhd, has been issued a certificate of ‘GMP compliance’ for its insulin manufacturing facility by HPRA (Ireland) as the representative European inspection authority,” Biocon spokesperson said in a statement on Thursday.
The certificate reflects that the agency considered the plant to be in compliance with principles and guidelines of good manufacturing practices for active substances, sterile drug products and quality control testing operations, the statement added. Biocon’s Malaysia facility was inspected by the European Medicines Agency (EMA) in April 2017.
- Dimon, Bezos, Buffett tap Atul Gawande for new healthcare firm
- CAPA India recommends creation of independent airports commission
- Education start-up Byju’s aims Rs1,400 crore revenue this year
- Taj Hotels wins bid to run The Connaught for 33 years
- Vedanta says acid leak severe at Sterlite copper plant in Tamil Nadu’s Thoothukudi
Editor's Picks »
- With fall of the last dove, MPC minutes portend more than one RBI rate hike
- RITES IPO ticks the valuations box, but not the growth one
- Is Reliance Jio really India’s most profitable telecom firm?
- How US-China trade war will affect India
- Dear ICICI Bank board, giving a red card to Chanda Kochhar is not enough